Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next-Gen Sequencing

Thierry Vilboux's Biography



Thierry Vilboux, Research Fellow, National Institutes of Health

Thierry Vilboux is an expert in molecular genetics.
Dr. Vilboux obtained his bachelor of science in cellular and molecular biology and genetics at the University of Rennes (France). He pursued his master in biology and health at the same university and in Paris, studying (dog genetics) in progressive rod cone degeneration. Focusing on canine genetic diseases as models for human illness, he completed his PhD of genetics in April 2007. Being an expert in genetics, Dr Vilboux soon joined the Medical Genetics Branch of the National Human Genome Research Institute (NHGRI) at the NIH in United States of America, where he did his postdoctoral studies. As he brought his expertise in this laboratory, he was instrumental in setting up the technology of genetic analysis and high throughput analysis. Within a short period, Dr Vilboux was able to author and co-author several publications that define scientific excellence in the identification of the genetic causes of medical diseases. At present, he was invited to extend his stay at NHGRI as a research fellow, to further his his career from bench work to translational medicine.

Dr. Vilboux obtained his bachelor of science in cellular and molecular biology and genetics at the University of Rennes (France). He pursued his master in biology and health at the same university and in Paris, studying (dog genetics) in progressive rod cone degeneration. Focusing on canine genetic diseases as models for human illness, he completed his PhD of genetics in April 2007. Being an expert in genetics, Dr Vilboux soon joined the Medical Genetics Branch of the National Human Genome Research Institute (NHGRI) at the NIH in United States of America, where he did his postdoctoral studies. As he brought his expertise in this laboratory, he was instrumental in setting up the technology of genetic analysis and high throughput analysis. Within a short period, Dr Vilboux was able to authDr. Thierry Vilboux is an expert in molecular genetics.
Dr. Vilboux obtained his bachelor of science in cellular and molecular biology and genetics at the University of Rennes (France). He pursued his master in biology and health at the same university and in Paris, studying (dog genetics) in progressive rod cone degeneration. Focusing on canine genetic diseases as models for human illness, he completed his PhD of genetics in April 2007. Being an expert in genetics, Dr Vilboux soon joined the Medical Genetics Branch of the National Human Genome Research Institute (NHGRI) at the NIH in United States of America, where he did his postdoctoral studies. As he brought his expertise in this laboratory, he was instrumental in setting up the technology of genetic analysis and high throughput analysis. Within a short period, Dr Vilboux was able to author and co-author several publications that define scientific excellence in the identification of the genetic causes of medical diseases. At present, he was invited to extend his stay at NHGRI as a research fellow, to further his his career from bench work to translational medicine.
or and co-author several publications that define scientific excellence in the identification of the genetic causes of medical diseases. At present, he was invited to extend his stay at NHGRI as a research fellow, to further his his career from bench work to translational medicine.

Thierry Vilboux Image

NBEAL2 is Mutated in Gray Platelet Syndrome and Required for Biogenesis of Platelet Alpha-Granules

Thursday, 19 April 2012 at 16:00

Add to Calendar ▼2012-04-19 16:00:002012-04-19 17:00:00Europe/LondonNBEAL2 is Mutated in Gray Platelet Syndrome and Required for Biogenesis of Platelet Alpha-Granules SELECTBIOenquiries@selectbiosciences.com

Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder that is characterized by large platelets that lack a-granules. By using a combination of next generation and traditional sequencing, we show that mutations in NBEAL2 (neurobeachin-like 2) cause GPS.


Add to Calendar ▼2012-04-19 00:00:002012-04-20 00:00:00Europe/LondonNext-Gen SequencingSELECTBIOenquiries@selectbiosciences.com